Diabetic Retinopathy Pipeline Therapeutics Development Report in H1 2017


Posted June 2, 2017 by justinebiel

Diabetic Retinopathy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Diabetic Retinopathy (Metabolic Disorders), complete with analysis.

 
ReportsnReports.com adds Diabetic Retinopathy - Pipeline Review, H1 2017 a new research reports in its store. Diabetic retinopathy is a complication of diabetes that affects the eyes. Diabetic retinopathy symptoms may include spots or dark strings floating in your vision (floaters), blurred vision, fluctuating vision, vision loss and difficulty with color perception. The predisposing factors include diabetes, high blood pressure, high cholesterol, pregnancy and tobacco use.

Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1020033

Diabetic Retinopathy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Diabetic Retinopathy (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Companies of the Diabetic Retinopathy Pipeline are Abzena Plc, Acucela Inc, Aerie Pharmaceuticals Inc, Aerpio Therapeutics Inc, Amakem NV, Antisense Therapeutics Ltd, Apollo Endosurgery Inc, BCN Peptides SA, Biomar Microbial Technologies, Charlesson LLC, Coherus BioSciences Inc, Crinetics Pharmaceuticals Inc, Dimerix Bioscience Pty Ltd, Dynamis Therapeutics Inc, EyeGene Inc, Foresee Pharmaceuticals LLC, Formycon AG, Icon Bioscience Inc, Islet Sciences Inc, Kodiak Sciences Inc, Kowa Company Ltd, Lupin Ltd, M's Science Corp, Mabion SA, Nemus Bioscience Inc, Oculis ehf, Ohr Pharmaceutical Inc, PanOptica Inc, Profarma, Promedior Inc, Regeneron Pharmaceuticals Inc, Ribomic Inc, Strongbridge Biopharma plc, Targazyme Inc, ThromboGenics NV, VESSL Therapeutics Ltd.

Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1020033 (This report is available at upto 25% Discount till June 02nd 2017.)

Scope
• The pipeline guide provides a snapshot of the global therapeutic landscape of Diabetic Retinopathy (Metabolic Disorders).
• The pipeline guide reviews pipeline therapeutics for Diabetic Retinopathy (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Diabetic Retinopathy (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Diabetic Retinopathy (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Diabetic Retinopathy (Metabolic Disorders)

Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1020033

List of Figures
Number of Products under Development for Diabetic Retinopathy, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Targets, H1 2017
Number of Products by Stage and Targets, H1 2017
Number of Products by Mechanism of Actions, H1 2017
Number of Products by Stage and Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017

About Us:
ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By justinebiel
Country India
Categories Health , News , Research
Tags diabetic retinopathy pipeline , diabetic retinopathy , diabetic retinopathy disorder , h1 2017 pipeline report
Last Updated June 2, 2017